00:00Novo Nordisk is laying off 9,000 employees, about 11% of its global workforce, as it faces
00:07intense competition in the booming weight loss drug market.
00:11The move comes as a new CEO is just months into the role and tries to reposition the
00:16company after a 60% stock drop and growing dominance from Eli Lillies Manjaro and ZepBound.
00:23The cuts highlight significant momentum in the industry, with rivals proving faster and
00:29more efficient in scaling production and innovation.
